Schrödinger 24th European User Group Meeting

May 19–21, 2026, Munich, Germany

Coriolis Pharma will take part in the 24th Schrödinger European User Group Meeting, a conference centered on computational approaches in pharmaceutical research. The event brings together scientists and industry professionals to discuss how molecular modeling and simulation support drug discovery and development.

Dr. Maximilian Allgöwer, Scientist at Coriolis Pharma, will contribute to the scientific program with a presentation titled:

“In dubio pro silico: Accelerating and de-risking formulation development of biologics”.

Our team will be in Munich throughout the meeting to exchange ideas with researchers and partners working at the interface of modeling, analytics, and drug product development.